Effectiveness of the diet low in fermentable carbohydrates as a treatment in adults diagnosed with irritable bowel syndrome: a Systematic Review
DOI:
https://doi.org/10.56294/saludcyt2024768Keywords:
Irritable Bowel Syndrome (IBS), FODMAP, Diet, Abdominal Pain and Inflammation of the IntestineAbstract
Currently the diet low in fermentable carbohydrates (FODMAP) is has established itself as a first-line strategy as a treatment for IBS in adults, so the purpose of this study is to analyze the effectiveness of the low diet in fermentable carbohydrates, as a treatment in adult patients diagnosed with IBS. Method: Systematic review (S.R.) based on randomized clinical trials (ECA) obtained from the databases Web of Science, PubMed, Cochrane Library, Scopus, EBSCO and Proquest. RCTs that included adults over 18 were reviewed years and older, both sexes, diagnosed with irritable bowel syndrome (IBS), who have contemplated a FODMAP restriction <112 gr/day, compared to a high FODMAP diet, regular diet with healthy habits. The risk of bias, according to the Cochrane collaboration. Results: five RCTs were found from Iran, Australia, China and Sweden, where four of them showed changes on the study variables: pain and distention abdominal, visceral hypersensitivity, alterations in depositional habits, transit abnormal levels of gas and vomiting, compared to their respective control groups. Conclusion: the evidence collected suggests that a low FODMAP diet in adults diagnosed with IBS significantly reduce the associated classic symptoms, generating decreases on the study variables, however, it is essential have adequate dietary advice from a professional nutritionist, to avoid nutritional deficiency and possible side effects
References
1. Nybacka S, Störsrud S, Lindqvist HM, Törnblom H, Simrén M, Winkvist A. Habitual FODMAP intake in relation to symptom severity and pattern in patients with irritable bowel syndrome. Nutrients. 2020;13(1):27. Disponible en: http://dx.doi.org/10.3390/nu13010027
2. Wilson B, Cox SR, Whelan K. Challenges of the low FODMAP diet for managing irritable bowel syndrome and approaches to their minimisation and mitigation. Proc Nutr Soc [Internet]. 2021;80(1):19–28. Disponible en: http://dx.doi.org/10.1017/S0029665120006990
3. Manning LP, Yao CK, Biesiekierski JR. Therapy of IBS: Is a low FODMAP diet the answer? Front Psychiatry [Internet]. 2020;11:865. Disponible en: http://dx.doi.org/10.3389/fpsyt.2020.00865
4. Altobelli E, Del Negro V, Angeletti P, Latella G. Low-FODMAP diet improves irritable bowel syndrome symptoms: A meta-analysis. Nutrients [Internet]. 2017;9(9):940. Disponible en: http://dx.doi.org/10.3390/nu9090940
5. Zugasti Murillo A, Estremera Arévalo F, Petrina Jáuregui E. Diet low in fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAPs) in the treatment of irritable bowel syndrome: Indications and design. Endocrinol Nutr (Engl Ed) [Internet]. 2016;63(3):132–8. Disponible en: http://dx.doi.org/10.1016/j.endoen.2015.10.014
6. Mearin F, Peña E, Balboa A. Importancia de la dieta en el síndrome del intestino irritable. Gastroenterol Hepatol [Internet]. 2014;37(5):302–10. Disponible en: http://dx.doi.org/10.1016/j.gastrohep.2013.12.010
7. Bellini M, Tonarelli S, Nagy AG, Pancetti A, Costa F, Ricchiuti A, et al. Low FODMAP diet: Evidence, doubts, and hopes. Nutrients [Internet]. 2020;12(1):148. Disponible en: http://dx.doi.org/10.3390/nu12010148
8. Liu J, Chey WD, Haller E, Eswaran S. Low-FODMAP diet for irritable bowel syndrome: What we know and what we have yet to learn. Annu Rev Med [Internet]. 2020;71(1):303–14. Disponible en: http://dx.doi.org/10.1146/annurev-med-050218-013625
9. Rej A, Sanders DS, Shaw CC, Buckle R, Trott N, Agrawal A, et al. Efficacy and acceptability of dietary therapies in non-constipated irritable bowel syndrome: A randomized trial of traditional dietary advice, the low FODMAP diet, and the gluten-free diet. Clin Gastroenterol Hepatol [Internet]. 2022;20(12):2876-2887.e15. Disponible en: http://dx.doi.org/10.1016/j.cgh.2022.02.045
10. Halmos EP, Power VA, Shepherd SJ, Gibson PR, Muir JG. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology [Internet]. 2014;146(1):67-75.e5. Disponible en: http://dx.doi.org/10.1053/j.gastro.2013.09.046
11. O’Keeffe M, Lomer MC. Who should deliver the low FODMAP diet and what educational methods are optimal: a review: Low FODMAP diet; education. J Gastroenterol Hepatol [Internet]. 2017;32 Suppl 1:23–6. Disponible en: http://dx.doi.org/10.1111/jgh.13690
12. Pérez y López N, Torres-López E, Zamarripa-Dorsey F. Respuesta clínica en pacientes mexicanos con síndrome de intestino irritable tratados con dieta baja en carbohidratos fermentables (FODMAP). Rev Gastroenterol Mex [Internet]. 2015;80(3):180–5. Disponible en: http://dx.doi.org/10.1016/j.rgmx.2015.06.008
13. Mearin F, Peña E, Balboa A. Importancia de la dieta en el síndrome del intestino irritable. Gastroenterol Hepatol [Internet]. 2014;37(5):302–10. Disponible en: http://dx.doi.org/10.1016/j.gastrohep.2013.12.010
14. Molina-Infante J, Serra J, Fernandez-Bañares F, Mearin F. The low-FODMAP diet for irritable bowel syndrome: Lights and shadows. Gastroenterol Hepatol (Engl Ed) [Internet]. 2016;39(2):55–65. Disponible en: http://dx.doi.org/10.1016/j.gastre.2016.01.004
15. Vakil N. Dietary fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAPs) and gastrointestinal disease. Nutr Clin Pract [Internet]. 2018;33(4):468–75. Disponible en: http://dx.doi.org/10.1002/ncp.10108
16. Frieling, T., Heise, J., Krummen, B., Hundorf, C., & Kalde, S. (2019). Tolerability of FODMAP-reduced diet in irritable bowel syndrome-efficacy, adherence, and body weight course. Zeitschrift Fur Gastroenterologie, 57(6), 740–744.
17. Sebastián Domingo JJ, Sánchez Sánchez C. La dieta baja en FODMAP, ¿es realmente eficaz y segura en el síndrome del intestino irritable?: una revisión panorámica. Semergen [Internet]. 2020;46(8):566–76. Disponible en: http://dx.doi.org/10.1016/j.semerg.2020.07.010
18. PRISMA 2020 Checklist Section and Topic Item # Checklist item Location where item is reported TITLE Title 1 Identify the report as a systematic review. (n.d.). https://doi.org/10.1136/bmj.n71
19. Frieling T, Heise J, Krummen B, Corinna H, Kalde S. Toleranz einer FODMAP-reduzierten Diät beim Reizdarmsyndrom – Effektivität, Adhärenz und Gewichtsentwicklung. En: 74 Jahrestagung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten mit Sektion Endoskopie – 13 Herbsttagung der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie gemeinsam mit den Arbeitsgemeinschaften der DGAV. Georg Thieme Verlag KG; 2019.
20. Manual Cochrane de revisiones sistemáticas de intervenciones | Cochrane Training. (n.d.). Retrieved November 26, 2023, from https://training.cochrane.org/es/manual-cochrane-de-revisiones-sistem%C3%A1ticas-de-intervenciones.
21. Schulz K, Altman D, Moher D. CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomized trials. BMJ. 2010; 340: 698-702.
22. Zahedi, M. J., Behrouz, V., & Azimi, M. (2018). Low fermentable oligo-di-monosaccharides and polyols diet versus general dietary advice in patients with diarrhea-predominant irritable bowel syndrome: A randomized controlled trial. Journal of Gastroenterology and Hepatology, 33(6), 1192–1199.
23. Mohseni F, Agah S, Ebrahimi-Daryani N, Taher M, Nattagh-Eshtivani E, Karimi S, et al. The effect of low FODMAP diet with and without gluten on irritable bowel syndrome: A double blind, placebo controlled randomized clinical trial. Clin Nutr ESPEN [Internet]. 2022;47:45–50. Disponible en: http://dx.doi.org/10.1016/j.clnesp.2021.12.019
24. Halmos EP, Power VA, Shepherd SJ, Gibson PR, Muir JG. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology [Internet]. 2014;146(1):67-75.e5. Disponible en: http://dx.doi.org/10.1053/j.gastro.2013.09.046
25. Zhang Y, Feng L, Wang X, Fox M, Luo L, Du L, et al. Low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols diet compared with traditional dietary advice for diarrhea-predominant irritable bowel syndrome: a parallel-group, randomized controlled trial with analysis of clinical and microbiological factors associated with patient outcomes. Am J Clin Nutr [Internet]. 2021;113(6):1531–45. Disponible en: http://dx.doi.org/10.1093/ajcn/nqab005
26. Böhn L, Störsrud S, Liljebo T, Collin L, Lindfors P, Törnblom H, et al. Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial. Gastroenterology [Internet]. 2015;149(6):1399-1407.e2. Disponible en: http://dx.doi.org/10.1053/j.gastro.2015.07.054
27. Algera JP, Demir D, Törnblom H, Nybacka S, Simrén M, Störsrud S. Low FODMAP diet reduces gastrointestinal symptoms in irritable bowel syndrome and clinical response could be predicted by symptom severity: A randomized crossover trial. Clin Nutr [Internet]. 2022;41(12):2792–800. Disponible en: http://dx.doi.org/10.1016/j.clnu.2022.11.001
28. Mohseni F, Agah S, Ebrahimi-Daryani N, Taher M, Nattagh-Eshtivani E, Karimi S, et al. The effect of low FODMAP diet with and without gluten on irritable bowel syndrome: A double blind, placebo controlled randomized clinical trial. Clin Nutr ESPEN [Internet]. 2022;47:45–50. Disponible en: http://dx.doi.org/10.1016/j.clnesp.2021.12.019
29. Eswaran SL, Chey WD, Han-Markey T, Ball S, Jackson K. A randomized controlled trial comparing the low FODMAP diet vs. Modified NICE guidelines in US adults with IBS-D. Am J Gastroenterol [Internet]. 2016;111(12):1824–32. Disponible en: http://dx.doi.org/10.1038/ajg.2016.434
30. Algera JP, Demir D, Törnblom H, Nybacka S, Simrén M, Störsrud S. Low FODMAP diet reduces gastrointestinal symptoms in irritable bowel syndrome and clinical response could be predicted by symptom severity: A randomized crossover trial. Clin Nutr [Internet]. 2022;41(12):2792–800. Disponible en: http://dx.doi.org/10.1016/j.clnu.2022.11.001
31. Wong Z, Mok C-Z, Majid HA, Mahadeva S. Early experience with a low FODMAP diet in Asian patients with irritable bowel syndrome: Diet and Asian Irritable Bowel Syndrome. JGH Open [Internet]. 2018;2(5):178–81. Disponible en: http://dx.doi.org/10.1002/jgh3.12069
32. Gibson, P Gibson PR. History of the low FODMAP diet: History of the low FODMAP diet. J Gastroenterol Hepatol [Internet]. 2017;32 Suppl 1:5–7. Disponible en: http://dx.doi.org/10.1111/jgh.13685
33. Fernández-Bañares F. Carbohydrate maldigestion and intolerance. Nutrients [Internet]. 2022;14(9):1923. Disponible en: http://dx.doi.org/10.3390/nu14091923
34. Wu J, Masuy I, Biesiekierski JR, Fitzke HE, Parikh C, Schofield L, et al. Gut-brain axis dysfunction underlies FODMAP-induced symptom generation in irritable bowel syndrome. Aliment Pharmacol Ther [Internet]. 2022;55(6):670–82. Disponible en: http://dx.doi.org/10.1111/apt.16812
Published
Issue
Section
License
Copyright (c) 2024 Lidia Díaz, Ninoska Leiva, María San Martin, Gabriela Pedraza (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
